AICDA and Miyoshi myopathy: Based on this, a novel pathogenetic model for MM was hypothesized, where aberrant AID activity contributes to tumor initiation, and provides a fertile ground where other late processes (i.e., APOBEC and signature #8) act and shape the final genomic landscape of overt MM [23].